// App-Quantinova.ai

: Definition of COPD phenotype depending on eosinophil count

Researchers

Presenter

  • Markus Polke

Principal Investigators

  • Nilab Polke

  • Matthias Rötting

  • Vasiliki Gerovasili

  • Ralf Eberhardt

  • Felix J F Herth

  • Daniela Gompelmann

Medical Centers

  • Pneumology & Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.

  • Respiratory and Transplant Medicine Department, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

  • Department of Pneumology and Critical Care Medicine, Thoraxklinik University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany

  • Pneumology and critical care medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRCH, German Center for Lung Research (DZL; Department of Internal Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria

Locations

  • Germany

  • United Kingdom

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved